NATR Quote, Financials, Valuation and Earnings

Better Choice has a net margin of 4.19% compared to Natures Sunshine Products's net margin of 13.42%. Natures Sunshine Products's return on equity of 6.27% beat Better Choice's return on equity of -199.75%.

Natures Sunshine Products has a consensus price target of $20.00, signalling upside risk potential of 40.15%. On the other hand Better Choice has an analysts' consensus of $10.00 which suggests that it could grow by 1558.38%. Given that Better Choice has higher upside potential than Natures Sunshine Products, analysts believe Better Choice is more attractive than Natures Sunshine Products.

Natures Sunshine Products has a beta of 1.164, which suggesting that the stock is 16.409% more volatile than S&P 500. In comparison Better Choice has a beta of 0.672, suggesting its less volatile than the S&P 500 by 32.807%.

Natures Sunshine Products has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Better Choice offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natures Sunshine Products pays -- of its earnings as a dividend. Better Choice pays out -- of its earnings as a dividend.

Natures Sunshine Products quarterly revenues are $113.2M, which are larger than Better Choice quarterly revenues of $11.4M. Natures Sunshine Products's net income of $4.7M is higher than Better Choice's net income of $1.5M. Notably, Natures Sunshine Products's price-to-earnings ratio is 26.92x while Better Choice's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natures Sunshine Products is 0.59x versus 0.02x for Better Choice. Usually stocks with elevated PS ratios are considered overvalued.

Healthy Choice Wellness has a net margin of 4.19% compared to Natures Sunshine Products's net margin of -3.52%. Natures Sunshine Products's return on equity of 6.27% beat Healthy Choice Wellness's return on equity of -43.51%.

Natures Sunshine Products has a consensus price target of $20.00, signalling upside risk potential of 40.15%. On the other hand Healthy Choice Wellness has an analysts' consensus of $2.00 which suggests that it could grow by 395.54%. Given that Healthy Choice Wellness has higher upside potential than Natures Sunshine Products, analysts believe Healthy Choice Wellness is more attractive than Natures Sunshine Products.

Natures Sunshine Products has a beta of 1.164, which suggesting that the stock is 16.409% more volatile than S&P 500. In comparison Healthy Choice Wellness has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Natures Sunshine Products has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Healthy Choice Wellness offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natures Sunshine Products pays -- of its earnings as a dividend. Healthy Choice Wellness pays out -- of its earnings as a dividend.

Natures Sunshine Products quarterly revenues are $113.2M, which are larger than Healthy Choice Wellness quarterly revenues of $20.3M. Natures Sunshine Products's net income of $4.7M is higher than Healthy Choice Wellness's net income of -$712.4K. Notably, Natures Sunshine Products's price-to-earnings ratio is 26.92x while Healthy Choice Wellness's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natures Sunshine Products is 0.59x versus 0.05x for Healthy Choice Wellness. Usually stocks with elevated PS ratios are considered overvalued.

Laird Superfood has a net margin of 4.19% compared to Natures Sunshine Products's net margin of -1.34%. Natures Sunshine Products's return on equity of 6.27% beat Laird Superfood's return on equity of -7.4%.

Natures Sunshine Products has a consensus price target of $20.00, signalling upside risk potential of 40.15%. On the other hand Laird Superfood has an analysts' consensus of $14.00 which suggests that it could grow by 121.87%. Given that Laird Superfood has higher upside potential than Natures Sunshine Products, analysts believe Laird Superfood is more attractive than Natures Sunshine Products.

Natures Sunshine Products has a beta of 1.164, which suggesting that the stock is 16.409% more volatile than S&P 500. In comparison Laird Superfood has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Natures Sunshine Products has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Laird Superfood offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natures Sunshine Products pays -- of its earnings as a dividend. Laird Superfood pays out -- of its earnings as a dividend.

Natures Sunshine Products quarterly revenues are $113.2M, which are larger than Laird Superfood quarterly revenues of $11.7M. Natures Sunshine Products's net income of $4.7M is higher than Laird Superfood's net income of -$156.2K. Notably, Natures Sunshine Products's price-to-earnings ratio is 26.92x while Laird Superfood's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natures Sunshine Products is 0.59x versus 1.43x for Laird Superfood. Usually stocks with elevated PS ratios are considered overvalued.

Usana Health Sciences has a net margin of 4.19% compared to Natures Sunshine Products's net margin of 3.72%. Natures Sunshine Products's return on equity of 6.27% beat Usana Health Sciences's return on equity of 6.41%.

Natures Sunshine Products has a consensus price target of $20.00, signalling upside risk potential of 40.15%. On the other hand Usana Health Sciences has an analysts' consensus of $61.00 which suggests that it could grow by 97.6%. Given that Usana Health Sciences has higher upside potential than Natures Sunshine Products, analysts believe Usana Health Sciences is more attractive than Natures Sunshine Products.

Natures Sunshine Products has a beta of 1.164, which suggesting that the stock is 16.409% more volatile than S&P 500. In comparison Usana Health Sciences has a beta of 0.630, suggesting its less volatile than the S&P 500 by 37.021%.

Natures Sunshine Products has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Usana Health Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natures Sunshine Products pays -- of its earnings as a dividend. Usana Health Sciences pays out -- of its earnings as a dividend.

Natures Sunshine Products quarterly revenues are $113.2M, which are smaller than Usana Health Sciences quarterly revenues of $249.5M. Natures Sunshine Products's net income of $4.7M is lower than Usana Health Sciences's net income of $9.3M. Notably, Natures Sunshine Products's price-to-earnings ratio is 26.92x while Usana Health Sciences's PE ratio is 16.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natures Sunshine Products is 0.59x versus 0.67x for Usana Health Sciences. Usually stocks with elevated PS ratios are considered overvalued.